APYX
Apyx Medical Corporation NASDAQ Listed Jan 2, 2019$4.11
-2.38%
vs $4.21
Mkt Cap $173.3M
52w Low $1.71
76.2% of range
52w High $4.86
50d MA $3.94
200d MA $3.54
P/E (TTM)
—
EV/EBITDA
—
P/B
11.7x
Debt/Equity
2.7x
ROE
-77.1%
P/FCF
-19.0x
RSI (14)
52.40
ATR (14)
$0.35
Beta
1.54
50d MA
$3.94
200d MA
$3.54
Avg Volume
201.0K
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
5115 Ulmerton Road · Clearwater, FL 33760 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 2.92 | +8.9% | +21.9% | +3.1% | +6.8% | +4.3% | -6.1% | — |
| Mar 10, 2026 | AMC | -0.06 | -0.03 | +50.0% | 3.45 | +10.7% | +13.9% | -7.9% | +0.3% | +1.1% | +1.9% | — |
| Nov 6, 2025 | AMC | -0.06 | -0.05 | +16.7% | 3.35 | -0.6% | +15.5% | +5.9% | -2.4% | +8.2% | -6.0% | — |
| Aug 7, 2025 | AMC | -0.09 | -0.09 | +3.5% | 1.96 | +12.2% | +11.2% | +2.3% | +0.4% | +4.9% | -9.8% | — |
| May 8, 2025 | AMC | -0.12 | -0.10 | +16.7% | 1.18 | +3.4% | -1.7% | -4.3% | +42.3% | -10.8% | +5.0% | — |
| Mar 13, 2025 | AMC | -0.13 | -0.12 | +7.7% | 1.04 | -1.9% | -3.8% | +13.0% | -5.3% | +1.9% | +6.4% | — |
| Nov 8, 2024 | AMC | -0.15 | -0.14 | +6.7% | 1.52 | -2.6% | -2.6% | -7.4% | -2.2% | -3.7% | -2.3% | — |
| Aug 8, 2024 | AMC | -0.18 | -0.19 | -5.6% | 1.02 | +16.7% | +2.0% | +1.9% | +3.8% | +7.3% | +16.9% | — |
| May 9, 2024 | AMC | -0.18 | -0.22 | -22.2% | 1.66 | -3.0% | -9.6% | -4.7% | -1.4% | +0.0% | +8.5% | — |
| Mar 21, 2024 | AMC | -0.13 | -0.19 | -46.2% | 1.32 | +0.8% | -5.3% | +1.6% | +0.8% | +10.2% | -3.5% | — |
| Nov 9, 2023 | AMC | -0.10 | -0.13 | -30.0% | 1.65 | +0.6% | +6.4% | -14.5% | +0.0% | -0.7% | +40.3% | — |
| Aug 10, 2023 | AMC | -0.12 | -0.11 | +8.3% | 4.21 | -15.4% | +20.0% | -4.6% | -1.5% | -4.2% | -1.1% | — |
| May 11, 2023 | AMC | -0.06 | -0.10 | -66.7% | 4.48 | +0.4% | +19.6% | +4.5% | +1.1% | +4.9% | +2.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 | BTIG | Upgrade | Neutral → Buy | — | $3.45 | $3.82 | +10.7% | +13.9% | -7.9% | +0.3% | +1.1% | +1.9% |
| Mar 11 | Craig-Hallum | Maintains | Buy → Buy | — | $3.45 | $3.82 | +10.7% | +13.9% | -7.9% | +0.3% | +1.1% | +1.9% |
| Nov 12 | Citizens | Upgrade | Market Perform → Market Outperform | — | $4.00 | $4.20 | +5.0% | +8.2% | -6.0% | -4.2% | +3.3% | -5.5% |
| Nov 10 | Stephens & Co. | Maintains | Overweight → Overweight | — | $1.65 | $1.66 | +0.6% | +6.4% | -14.5% | +0.0% | -0.7% | +40.3% |
| Aug 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.21 | $3.56 | -15.4% | +20.0% | -4.6% | -1.5% | -4.2% | -1.1% |
| Jun 15 | Lake Street | Maintains | Buy → Buy | — | $6.90 | $7.00 | +1.4% | +0.7% | +0.1% | +0.9% | +4.4% | -1.0% |
| May 24 | JMP Securities | Maintains | Market Perform → Perform | — | $5.98 | $5.99 | +0.2% | -0.7% | +1.2% | +8.0% | -4.8% | +2.4% |
| May 12 | Lake Street | Maintains | Buy → Buy | — | $4.48 | $4.50 | +0.4% | +19.6% | +4.5% | +1.1% | +4.9% | +2.9% |
| Aug 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.28 | $9.84 | -4.3% | -19.7% | -9.5% | -3.2% | -2.4% | +0.6% |
| Jul 19 | Lake Street | Maintains | Buy → Buy | — | $8.04 | $8.38 | +4.2% | +6.6% | +14.1% | -3.6% | -4.0% | +2.2% |
| May 20 | Lake Street | Maintains | Buy → Buy | — | $3.41 | $3.59 | +5.3% | +3.2% | -1.1% | -1.1% | +7.6% | +51.9% |
| Aug 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $11.13 | $11.03 | -0.9% | -2.0% | -7.1% | +2.6% | -1.2% | -0.8% |
| May 12 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $3.65 | $3.64 | -0.3% | -11.8% | +2.2% | +10.0% | -0.3% | +16.6% |
| Nov 12 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.22 | $7.75 | +7.3% | +10.8% | -1.4% | -0.5% | -5.9% | -5.4% |
| Apr 2 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $6.95 | $4.36 | -37.3% | -35.8% | -2.7% | -7.6% | -0.5% | -1.0% |
| Sep 6 | JMP Securities | Maintains | Market Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Nov 21 | Piper Sandler | Maintains | Overweight → Overweight | — | — | — | — | — | — | — | — | — |
| Apr 21 | JMP Securities | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Apr 15 | Craig-Hallum | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
No insider trades available.
8-K · 1.01
!! High
Apyx Medical Corporation -- 8-K 1.01: Material Agreement
Apyx Medical promoted Board Chairman Stavros Vizirgianakis to Executive Chairman, a structural change that consolidates leadership authority and may signal operational strategy shifts ahead.
Jun 17
8-K · 8.01
!! High
Apyx Medical Corporation -- 8-K 8.01: Material Event / Announcement
I cannot provide a specific analysis without the actual press release content, as the filing only references an attached exhibit without disclosing the material event details.
May 21
8-K · 8.01
!! High
Apyx Medical Corporation -- 8-K 8.01: Material Event / Announcement
May 14
8-K · 2.02
!! High
Apyx Medical Corporation -- 8-K 2.02: Earnings Results
Apyx Medical reported first-quarter 2026 results, with financial performance details available in the attached press release for investors to evaluate operational trends.
May 7
8-K
Unknown — 8-K Filing
Apyx Medical's 57-58M FY2026 revenue guidance represents 197-204% growth from Q4 2025 run-rate, signaling strong AYON commercialization momentum that could justify expansion valuation if execution meets targets.
Mar 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Archon Capital Management Llc | 2,790,923 | $10M | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 1,555,272 | $6M | New | Mar 2026 |
| 3 | Aigh Capital Management Llc | 1,104,970 | $4M | — | Mar 2026 |
| 4 | Silverberg Bernstein Capital Management Llc | 1,041,070 | $4M | Added | Mar 2026 |
| 5 | Essex Investment Management Co Llc | 901,398 | $3M | New | Mar 2026 |
| 6 | Commonwealth Equity Services, Llc | 663,541 | $2M | — | Dec 2025 |
| 7 | Sei Investments Co | 598,255 | $2M | Added | Mar 2026 |
| 8 | Taylor Frigon Capital Management Llc | 414,559 | $2M | Reduced | Mar 2026 |
| 9 | Renaissance Technologies Llc | 302,395 | $1M | Added | Mar 2026 |
| 10 | Legato Capital Management Llc | 280,889 | $1M | New | Mar 2026 |
| 11 | Susquehanna International Group, Llp | 267,561 | $987K | Added | Mar 2026 |
| 12 | Millennium Management | 262,058 | $967K | Added | Mar 2026 |
| 13 | Informed Momentum Co Llc | 246,435 | $909K | — | Mar 2026 |
| 14 | Huntleigh Advisors, Inc. | 245,920 | $907K | Added | Mar 2026 |
| 15 | Ubs Group Ag | 231,345 | $854K | Added | Mar 2026 |
| 16 | Kingsview Wealth Management, Llc | 208,788 | $770K | Added | Mar 2026 |
| 17 | Jane Street Group, Llc | 168,238 | $589K | New | Dec 2025 |
| 18 | Caption Management, Llc | 160,407 | $561K | Added | Dec 2025 |
| 19 | Northern Trust Corp | 111,449 | $411K | Added | Mar 2026 |
| 20 | Citadel Advisors Llc | 107,798 | $398K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 17
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | ROYCE MICRO-CAP TRUST, INC. | 663,269 | $2M | Mar 2026 |
| 2 | Royce Small-Cap Opportunity Fund | 589,063 | $2M | Mar 2026 |
| 3 | Royce Micro-Cap Fund | 586,780 | $2M | Mar 2026 |
| 4 | Royce Capital Fund - Micro-Cap Portfolio | 215,125 | $794K | Mar 2026 |
| 5 | Fidelity Extended Market Index Fund | 170,136 | $556K | Feb 2026 |
| 6 | 1290 Essex Small Cap Growth Fund | 131,402 | $528K | Jan 2026 |
| 7 | Taylor Frigon Core Growth Fund | 128,436 | $420K | Feb 2026 |
| 8 | iShares Micro-Cap ETF | 87,486 | $323K | Mar 2026 |
| 9 | SIIT SMALL CAP II FUND | 79,900 | $261K | Feb 2026 |
| 10 | Ultra-Small Company Market Fund | 55,300 | $204K | Mar 2026 |
| 11 | Fidelity Total Market Index Fund | 56,118 | $184K | Feb 2026 |
| 12 | Fidelity Series Total Market Index Fund | 45,971 | $150K | Feb 2026 |
| 13 | Fidelity Nasdaq Composite Index Fund | 20,572 | $67K | Feb 2026 |
| 14 | Victory Extended Market Index Fund | 3,711 | $15K | Jan 2026 |
| 15 | Small Cap Core Fund | 3,238 | $12K | Mar 2026 |
| 16 | Dimensional U.S. Core Equity 2 ETF | 713 | $3K | Jan 2026 |
| 17 | Guggenheim Active Allocation Fund | 185 | $605 | Feb 2026 |
Valuation
Market Cap
$173.3M
Enterprise Value
$176.4M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.22x
P/B
11.68x
P/S
3.10x
P/FCF
-19.01x
EV/EBITDA
—
Shares Out
42.2M
Financials (TTM)
Revenue
$55.9M
Net Income
-$9.2M
EBITDA
-$2.4M
Free Cash Flow
-$9.1M
Op Cash Flow
-$8.0M
EPS Basic
$-0.27
EPS Diluted
$-0.22
EPS Forward
$-0.32
Gross Margin
32.3%
Op Margin
-7.7%
Net Margin
-16.4%
Balance Sheet
Total Assets
$66.8M
Total Liab.
$52.0M
Total Equity
$14.8M
Cash
$31.7M
LT Debt
$34.8M
Book Value/Sh
$0.35
Debt/Equity
2.71x
Current Ratio
5.00
Quick Ratio
4.26
Returns & Growth
ROE
-77.1%
ROA
-16.8%
ROIC
-11.6%
Rev Growth YoY
+9.9%
EPS Growth YoY
+59.1%
Price Returns
2W
-8.4%
1M
+20.0%
3M
+22.2%
6M
-0.4%
12M
+156.1%
Technicals
52W High
$4.86
52W Low
$1.71
50d MA
$3.94
200d MA
$3.54
RSI (14)
52.40
ATR (14)
$0.35
Beta
1.54
Avg Volume
201K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.00
High
$6.00
Low
$6.00
Median
$6.00
Data updated apr 24, 2026 6:38pm
· Source: financialmodelingprep.com